Moderate to Severe Asthma
Also known as: Moderate/Severe Asthma / Moderate-to-Severe Asthma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12159 | Dupilumab | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB12159 | Dupilumab | Interleukin-4 receptor subunit alpha | target |
| DB12159 | Dupilumab | Interleukin-13 | target |
| DB12159 | Dupilumab | Interleukin-4 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18855 | Povorcitinib | 2 | Recruiting | 1 |
| DB18990 | Stapokibart | 2 / 3 | Recruiting | 1 |
| DB15090 | Tezepelumab | 3 | Completed | 1 |
| DB12023 | Benralizumab | 4 | Recruiting | 1 |
| DB12159 | Dupilumab | 4 | Recruiting | 1 |